136 related articles for article (PubMed ID: 31554861)
21. Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation.
Qian J; Tikk K; Werner S; Balavarca Y; Saadati M; Hechtner M; Brenner H
J Clin Epidemiol; 2018 Dec; 104():24-34. PubMed ID: 30076979
[TBL] [Abstract][Full Text] [Related]
22. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
23. Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center.
Gren LH; Lamerato LE; Wright P; Marcus PM
Rev Recent Clin Trials; 2015; 10(3):194-9. PubMed ID: 26238206
[TBL] [Abstract][Full Text] [Related]
24. [Population-based gastric cancer screening in Zhuanghe, Liaoning, from 1997 to 2011].
Yuan Y
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):538-42. PubMed ID: 22967474
[TBL] [Abstract][Full Text] [Related]
25. Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial.
Prorok PC; Wright P; Riley TR; Kramer BS; Berg CD; Gohagan JK
Rev Recent Clin Trials; 2018; 13(4):257-273. PubMed ID: 29629665
[TBL] [Abstract][Full Text] [Related]
26. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
[TBL] [Abstract][Full Text] [Related]
27. Cancer screening in Korea, 2012: results from the Korean National Cancer Screening Survey.
Suh M; Choi KS; Lee YY; Park B; Jun JK
Asian Pac J Cancer Prev; 2013; 14(11):6459-63. PubMed ID: 24377550
[TBL] [Abstract][Full Text] [Related]
28. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
[TBL] [Abstract][Full Text] [Related]
29. The impact of screening on cancer incidence and mortality in Missouri, USA, 2004-2013.
Yoshida Y; Schmaltz CL; Jackson-Thompson J; Simoes EJ
Public Health; 2018 Jan; 154():51-58. PubMed ID: 29197686
[TBL] [Abstract][Full Text] [Related]
30. Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people.
Wang Y; Jiang X; Dong S; Shen J; Yu H; Zhou J; Li J; Ma H; He E; Skog S
Cancer Biomark; 2016 Mar; 16(4):529-36. PubMed ID: 27002755
[TBL] [Abstract][Full Text] [Related]
31. Age-standardized cancer-incidence trends in Canada, 1971-2015.
Brenner DR; Ruan Y; Shaw E; O'Sullivan D; Poirier AE; Heer E; Villeneuve PJ; Walter SD; Friedenreich CM; Smith L; De P
CMAJ; 2019 Nov; 191(46):E1262-E1273. PubMed ID: 31740536
[TBL] [Abstract][Full Text] [Related]
32. [Screening for cancer].
Seifert U; Schlanstedt-Jahn U; Klug SJ
Internist (Berl); 2015 Oct; 56(10):1114-23. PubMed ID: 26384500
[TBL] [Abstract][Full Text] [Related]
33. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
34. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.
Miller EA; Pinsky PF; Schoen RE; Prorok PC; Church TR
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):101-110. PubMed ID: 30502933
[TBL] [Abstract][Full Text] [Related]
35. Colorectal, cervical and prostate cancer screening in Australians with severe mental illness: Retrospective nation-wide cohort study.
Tuesley KM; Jordan SJ; Siskind DJ; Kendall BJ; Kisely S
Aust N Z J Psychiatry; 2019 Jun; 53(6):550-558. PubMed ID: 30501394
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
37. Comparative evaluation of novel screening strategies for colorectal cancer screening in China (TARGET-C): a study protocol for a multicentre randomised controlled trial.
Chen H; Li N; Shi J; Ren J; Liu C; Zhang Y; Jiang Z; Zhang Z; Dai M
BMJ Open; 2019 Apr; 9(4):e025935. PubMed ID: 31005927
[TBL] [Abstract][Full Text] [Related]
38. Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers.
Malagón M; Ramió-Pujol S; Serrano M; Serra-Pagès M; Amoedo J; Oliver L; Bahí A; Mas-de-Xaxars T; Torrealba L; Gilabert P; Miquel-Cusachs JO; García-Nimo L; Saló J; Guardiola J; Piñol V; Cubiella J; Castells A; Aldeguer X; Garcia-Gil J
Aliment Pharmacol Ther; 2019 Jun; 49(11):1410-1420. PubMed ID: 31025420
[TBL] [Abstract][Full Text] [Related]
39. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2.
Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X
Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098
[TBL] [Abstract][Full Text] [Related]
40. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
